RNA extracted from diagnostic tumor samples of 52 patients affected by DLBCL was analyzed on the nCounter system using the PanCancer Immune Profiling Panel. Overall design: Gene expression profile wer
To investigate whether the gut microbiota in patients with diffuse large B-cell lymphoma (DLBCL) had changed at the time of initial diagnosis, we compared the dominant gut microbiota and diversity in
To investigate whether the gut microbiota in patients with diffuse large B-cell lymphoma (DLBCL) had changed at the time of initial diagnosis, we compared the dominant gut microbiota and diversity in
